PHT Provides App of FDA Roadmap for COA Measurements
PHT Corporation is offering an app based on the FDA's Clinical Outcome Assessment Qualification Program
PHT Corporation is offering an app based on the FDA's Clinical Outcome Assessment Qualification Program. The FDA Roadmap App from PHT provides sponsors with the mobile capability on Android phones and tablets that optimizes the FDA-based website information. The FDA's Roadmap to Patient-Focused Outcomes Measurement in Clinical Trials highlights the process by which a sponsor should consider, choose and/or develop a patient-focused outcome measurement strategy in a clinical program.
Read the full release here.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
